Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 5th ed., Arlington, VA: American Psychiatric Publishing, 2013.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. The N-SSATS Report: Trends in the use of methadone and buprenorphine at substance abuse treatment facilities: 2003 to 2011 2013. http://archive.samhsa.gov/data/2k13/NSSATS107/sr107-NSSATS-BuprenorphineTrends.htm (accessed March 8, 2016).
   Google Scholar
• Centers for Disease Control. Prescription painkiller overdoses in the US. Vitalsigns. Vol November 2011 2011. http://www.cdc.gov/vitalsigns/pdf/2011-2011-vitalsigns.pdf (accessed March 14, 2016)
   Google Scholar
• Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13(5):401–35.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Drug abuse warning network, 2011: National estimates of drug-related emergency department visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Administration, 2013.
   Google Scholar
• Murphy S, Ku J, Kochaneck K. Deaths: final data for 2010. Natl Vital Stat Rep 2013; 61(4):1–118.
   PubMedGoogle Scholar
• Paulozzi LJ. Prescription drug overdoses: a review. J Safety Res 2012; 43(4):283–9.
   PubMed Web of Science ®Google Scholar
• Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 2011; 12(4):657–67.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284(13):1689–95.
   PubMed Web of Science ®Google Scholar
• Ferri M, Finlayson AJ, Wang L, Martin PR. Predictive factors for relapse in patients on buprenorphine maintenance. Am J Addict 2014; 23(1):62–7.
   PubMed Web of Science ®Google Scholar
• Mattoo SK, Chakrabarti S, Anjaiah M. Psychosocial factors associated with relapse in men with alcohol or opioid dependence. Indian J Med Res 2009; 130(6):702–8.
   PubMed Web of Science ®Google Scholar
• Gossop M, Stewart D, Browne N, Marsden J. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction 2002; 97(10):1259–67.
   PubMed Web of Science ®Google Scholar
• Jann M, Kennedy WK, Lopez G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J Pharm Pract 2014; 27(1):5–16.
   PubMedGoogle Scholar
• Savage SR, Kirsh KL, Passik SD. Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract 2008; 4(2):4–25.
   PubMedGoogle Scholar
• Coleman J, Katz E, Menzel H. The diffusion of an innovation among physicians. Sociometry 1957; 20(4): 253–70.
   Google Scholar
• Iyengar R, Van den Bulte C, Valente TW. Opinion leadership and social contagion in new product diffusion. Cambridge, MA: Marketing Science Institute, 2008.
   Google Scholar
• Christakis NA, Fowler JH. Contagion in prescribing behavior among networks of doctors. Market Sci 2011; 30(2):213–6.
   Web of Science ®Google Scholar
• Fattore G, Frosini F, Salvatore D, Tozzi V. Social network analysis in primary care: the impact of interactions on prescribing behaviour. Health Policy 2009; 92(2–3):141–8.
   PubMed Web of Science ®Google Scholar
• Nair HS, Manchanda P, Bhatia T. Asymmetric social interactions in physician prescription behavior: the role of opinion leaders. J Mark Res 2010; 47(5):883–95.
   Web of Science ®Google Scholar
• Barnett ML, Landon BE, O'Malley AJ, Keating NL, Christakis NA. Mapping physician networks with self-reported and administrative data. Health Serv Res 2011; 46(5):1592–609.
   PubMed Web of Science ®Google Scholar
• Callaly T, Trauer T, Munro L, Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Aust N Z J Psychiatry 2001; 35(5):601–5.
   PubMed Web of Science ®Google Scholar
• Brooner RK, King VL, Kidorf M, Schmidt CW, Jr., Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psych 1997; 54(1):71–80.
   PubMed Web of Science ®Google Scholar
• Ahmadi J, Majdi B, Mahdavi S, Mohagheghzadeh M. Mood disorders in opioid-dependent patients. J Affect Disord 2004; 82(1):139–42.
   PubMed Web of Science ®Google Scholar
• Center for Substance Abuse Treatment. Chapter 10. Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment improvement protocol (TIP), Vol 43., Rockville, MD: Subtance Abuse and Mental Health Services Administration, 2005.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Applying the substance abuse confidentiality regulations (FAQ). Substance abuse confidentiality regulations 2015. http://www.samhsa.gov/about-us/who-we-are/laws/confidentiality-regulations-faqs (accessed November 10, 2015).
   Google Scholar
• McCarty D, Janoff S, Coplan P, et al. Detection of opioid overdoses and poisonings in electronic medical records as compared to medical chart reviews 2014. http://www.fda.gof/downloads/Drugs/NewsEvents/UCM398787.pdf (accessed June 28, 2016).
   Google Scholar
• United States Department of Agriculture Economic Research Service. 2013 rural-urban continuum codes 2013. http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx-.VAcgRcVdXOE (accessed September 3, 2014).
   Google Scholar
• Blumstein A. Youth violence, guns, and the illicit-drug industry. J Crim Law Criminal 1995; 86(1): 10–36.
   Web of Science ®Google Scholar
• Corsaro N, Hunt ED, Hipple NK, McGarrell EF. The impact of drug market pulling levers policing on neighborhood violence. Criminal Public Policy 2012; 11(2):167–199.
   Google Scholar
• Clauset A, Newman MEJ, Moore C. Finding community structure in very large networks. Phys Rev E 2004; 70(6): 165-166.
   Google Scholar
• Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal, Complex Systems 2006; 1695(5):1–9.
   Google Scholar
• R Core Team. R: A language and environment for statistical computing [internet]. Vienna, Austria: R Foundation for statistical computing, 2013. http://www.r-project.org (accessed March 14, 2016).
   Google Scholar
• Paulozzi L. Populations at risk for opioid overdose. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM300859.pdf (accessed April 18, 2016).
   Google Scholar
• Coolen P, Best S, Lima A, Sabel JC, Paulozzi L. Overdose deaths involving prescription opioids among Medicaid enrollees—Washington, 2004–2007. MMWR Morb Mortal Wkly Rep 2009; 58(42):1171–5.
   PubMedGoogle Scholar
• Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993–2009. PLoS One 2013; 8(2):e54496.
   PubMed Web of Science ®Google Scholar
• Detsky AS. Regional variation in medical care. N Engl J Med 1995; 333(9):589–90.
   PubMed Web of Science ®Google Scholar
• Ghitza UE, Sparenborg S, Tai B. Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems. Subst Abuse Rehabil 2011; 2011(2):125–31.
   PubMedGoogle Scholar
• Tai B, Wu LT, Clark HW. Electronic health records: essential tools in integrating substance abuse treatment with primary care. Subst Abuse Rehabil 2012; 3:1–8.
   PubMedGoogle Scholar
• Wu LT, Gersing KR, Swartz MS, Burchett B, Li TK, Blazer DG. Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults. J Psychiatr Res 2013; 47(4):555–63.
   PubMed Web of Science ®Google Scholar
• Pradel V, Frauger E, Thirion X, et al. Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiol Drug Saf 2009; 18(1):36–43.
   PubMed Web of Science ®Google Scholar
• Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled substances. Med Care 2012; 50(6):494–500.
   PubMed Web of Science ®Google Scholar
• Han H, Kass PH, Wilsey BL, Li CS. Increasing trends in Schedule II opioid use and doctor shopping during 1999–2007 in California. Pharmacoepidemiol Drug Saf 2014; 23(1):26–35.
   PubMed Web of Science ®Google Scholar
• Stein BD, Sorbero M, Burns RM, et al. The Impact of State Policies on the Use of Buprenorphine Among Medicaid Enrollees Identified with Opioid Use Disorders. Addiction Health Services Research (AHSR) Conference. CA: Marina del Rey, October 13-17, 2015.
   Google Scholar
• Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015; 350:h2698.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies-tackling the opioid-overdose epidemic. N Engl J Med 2014; 370(22):2063–6.
   PubMed Web of Science ®Google Scholar
• Clark T, Eadie J, Kreiner P, Strickler G. Prescription drug montoring programs: an assessment of the evidence for best practices. Waltham, MA: Brandeis University, 2012.
   Google Scholar